These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6791984)

  • 1. Tumoricidal activity of peritoneal exudate cells from rats treated with mitomycin C.
    Ogura T; Shindo H; Namba M; Yamamura Y
    Gan; 1980 Dec; 71(6):920-1. PubMed ID: 6791984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
    Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
    Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of therapeutic effect in experimental chemoimmunotherapy for rat ascites tumor.
    Ogura T; Shinzato O; Sakatani M; Shindo H; Namba M; Kishimoto S; Yamamura Y
    Cancer Immunol Immunother; 1982; 14(2):67-72. PubMed ID: 6821517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats.
    Ogura T; Shindo H; Shinzato O; Namba M; Masuno T; Inoue T; Kishimoto S; Yamamura Y
    Cancer Immunol Immunother; 1982; 13(2):112-7. PubMed ID: 6819079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 7. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A; Tandon P; Sarna S
    Arch Geschwulstforsch; 1985; 55(1):47-61. PubMed ID: 3872651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of macrophage activation with antitumor effect on rat syngeneic fibrosarcoma by Nocardia rubra cell wall skeleton.
    Ogura T; Namba N; Hirao F; Yamamura Y; Azuma I
    Cancer Res; 1979 Nov; 39(11):4706-12. PubMed ID: 498096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of tumour inhibition by activated macrophages in vitro.
    Orinda DA
    East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
    [No Abstract]   [Full Text] [Related]  

  • 11. The mediator of cellular immunity. VIII. Effect of mitomycin C on specifically sensitized lymphocytes.
    McGregor DD; Logie PS
    Cell Immunol; 1975 Jan; 15(1):69-81. PubMed ID: 233966
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the in vitro cytolytic effect of hepatic, splenic and peritoneal macrophages from glucan-treated mice on sarcoma M5076.
    Sherwood ER; Williams DL; Di Luzio NR
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):157-61. PubMed ID: 3713379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibited migration of peritoneal exudate cells harvested from rats bearing syngeneic or autochthonous tumours.
    Medzihradský J; Kalafut F
    Neoplasma; 1972; 19(2):147-9. PubMed ID: 5063365
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of PSK on specific tumor immunity to syngeneic tumor cells.
    Tsuru S; Nomoto K
    J Clin Lab Immunol; 1983 Apr; 10(4):215-9. PubMed ID: 6408260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of immunotherapy and chemotherapy to experimental tumors in rats.
    Hosokawa M; Sendo F; Gotoda E; Kobayashi H
    Gan; 1971 Feb; 62(1):57-60. PubMed ID: 5553381
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of proliferation in mixed cultures of mouse tumor cells and nonimmune peritoneal cells. II. Stimulation of tumor cells by macrophages and of lymphocytes by a tumor cell product.
    Nelson M; Nelson DS
    J Natl Cancer Inst; 1985 Mar; 74(3):637-45. PubMed ID: 3919198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
    Ogura T; Hara H; Yokota S; Hosoe S; Kawase I; Kishimoto S; Yamamura Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6371-5. PubMed ID: 4063987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of combined use of OK-432 and yeast cell wall with mitomycin-C in mice.
    Mashiba H; Gojobori M; Matsunaga K
    Gan; 1977 Oct; 68(5):703-8. PubMed ID: 590687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.